We are happy to announce that our paper “Rothia similimucilaginosa sp. nov., isolated from the human nasal cavity” is now published in the International Journal of Systematic and Evolutionary Microbiology! We previously identified Rothia spp. as beneficial bacteria in the upper respiratory tract that inhibit the nasal pathobiont Moraxella catarrhalis using a secreted peptidoglycan endopeptidase (see here for more details). As part of that work, we isolated four novel Rothia spp. In this paper, Mercedes and our collaborators, Jacobey King and Paul Lawson from the University of Oklahoma, performed a comprehensive characterization of these Rothia. We confirmed that these isolates represented a novel species, which we named Rothia similimucilaginosa. Read more about the description of these Rothia here.
This is Mercedes’ first paper from the Stubbendieck Lab! Congrats Mercedes!